Clinical Trial Update: A Food Effect Study of LY03020 in Healthy Subjects [Phase 1]

View source ↗

Summary

This is a Phase 1 food-effect study of LY03020 in healthy subjects sponsored by Luye Pharma Group Ltd.; the trial is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease Psychosis
• Schizophrenia

Drugs mentioned

• LY03020

Snippet

Sponsor: Luye Pharma Group Ltd. | Conditions: Schizophrenia, Alzheimer's Disease Psychosis | Phase 1 | Status: ACTIVE_NOT_RECRUITING